4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0000950170-24-071543
10% owner acquired 3,728,738 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ARCH Venture Partners XII, LLC 10% owner | 2024-06-10 | Conversion | +3,728,738 | 3,728,738 | I | ||
| Derivatives | |||||||
| ARCH Venture Partners XII, LLC 10% owner | 2024-06-10 | Conversion · Series A Preferred Stock | −20,000,000 | 0 | I | ||
| ARCH Venture Partners XII, LLC 10% owner | 2024-06-10 | Conversion · Series B Preferred Stock | −11,924,138 | 0 | I | ||
Loading xslF345X05/ownership.xml…